We now keep track of our FOIA requests here.
Recent NIH FOIAs: https://www.keionline.org/foia/nih
Older logs and pages about selected Freedom of Information Act (FOIA) requests filed by KEI.
Centers for Disease Control and Prevention (CDC)
- March 3, 2015: CDC FOIA regarding intellectual property on avian flu intellectual property rights
- March 1, 2017: CDC FOIA shows US, WHO opposed request to discuss UNSG’s High-Level Panel on Access to Medicines Report at EB
Department of Commerce
- April 26, 2011: Confirmation that Obama Administration was “lone hold out” for releasing bracketed ACTA text to the public in Summer of 2010
- October 5, 2012: US department of Commerce heavily redacts FOIA request regarding Thailand compulsory license
Department of State
- October 13, 2007: Dept of State cables on Brazil negotiations on prices and patents for AIDS drugs
- June 12, 2013: Four Department of State cables on Thailand, for Special 301 Review (Years 2009 to 2011)
Food and Drug Administration (FDA)
- October 19, 2010: Response by FDA to KEI’s FOIA Request Regarding the PSM India Summit of May 11, 2010 in New Delhi
National Aeronautics and Space Administration (NASA)
- October 8, 2009: NASA FOIA Requests
National Institutes of Health (NIH)
- May 4, 2016: NIH FOIA office withholds all records related to exclusive license on HER2+ breast cancer treatment technology
- September 17, 2016: NIH Waivers for U.S. Manufacturing Requirements for Federally-Funded Drugs, 2011 to May 2015
- September 20, 2016: 500+ Pages of Documents on NFL Attempts to Influence NIH Funding of Concussion Studies
- December 20, 2016: Front page New York Times story explores Kite Pharma’s profitable relationship with NIH regarding expensive cancer drug
- June 29, 2018: KEI Files Expedited FOIA Request Regarding NIH Prospective Exclusive License of CAR T Technology
U.S. Patent and Trademark Office (USPTO)
- October 20, 2009: USPTO trying to block KEI FOIA over WIPO treaty and stakeholder platform for reading disabilities
- March 6, 2010: The USPTO-Pfizer collaboration to change India’s laws on patents and test data
- March 22, 2010: Tie up with Pfizer in India a mistake, says USPTO
- June 12, 2013: US Chamber letter to USPTO opposes fair use, expresses “concerns” about WIPO treaty for blind
- June 23, 2013: USPTO releases 142 pages of emails sent by MPAA to USPTO over the treaty for the blind
U.S. Trade Representative (USTR)
- May 24, 2009: Daily Calendar for Ambassador Ron Kirk, March 20 to May 1, 2009
- November 11, 2009: Daily Calendar for USTR head Ambassador Ron Kirk, for May to September 2009
- March 7, 2010: In 2007, US Ambassador Ralph Boyce was pleased that Abbott withdrew life saving drugs from market in Thailand
- September 9, 2010: USTR’s February 10, 2009 memo on Transparency Soup
- March 24, 2011: KEI to appeal USTR rejection of FOIA of Congressional Research Service (CRS) study of ACTA
- November 27, 2013: USTR FOIA, 127 pages of emails between industry and USTR TPP negotiators
- June 13, 2014: TTIP: Anti-Transparency Rules laid out in USTR letter to DG-Trade
- August 5, 2014: Money speaks: USTR releases letters from Congress backing PhRMA on exclusive rights biologic test data in TPP
- June 18, 2015: FOIA regarding General Electric’s lobbying of USTR to oppose WIPO Treaty for the Blind
- September 11, 2015: USTR provides the names of the TPP Chapters (as of September 10, 2015)
- September 21, 2015: USTR releases documents from 2012 R&D treaty negotiations
- September 22, 2016: NAM told USTR the EU position on LDC extension made a mockery of international trading system
- June 8, 2017: In 2015 Novartis asked U.S. Dept of Commerce to Pressure Colombia Against Compulsory License on Glivec
- November 28, 2018: Pfizer asked USTR to block Malaysia requirement on drug price transparency
- November 28, 2018: Communications between Gilead and USTR regarding Malaysia compulsory license on HCV patents, 2017 to May 2018
- November 29, 2018: Pfizer’s efforts to block Colombia’s accession to the OECD in 2017-2018
White House
- March 13, 2009: White House says ACTA text a State Secret. EU parliament says time for more transparency
- March 14, 2009: March 2009 news stories on the denial of access to ACTA documents under FOIA on national security grounds
- July 31, 2009: White House: ACTA still “secret in the interest of national defense or foreign policy”
- April 21, 2011: White House rejects administrative appeal on FOIA request for CRS study of ACTA
- January 10, 2013: White House refuses FOIA request for documents on country positions on transparency of ACTA negotiations
Other KEI pages about FOIA requests
Department of Health and Human Services (DHHS) FOIA Requests
Department of Defense (DOD) FOIA Requests
Department of Energy (DOE) FOIA Requests
Department of State FOIA Requests
Office of Management and Budget
Department of Agriculture (USDA) FOIA Requests
US Patent and Trademark Office (USPTO) FOIA requests
United States Trade Representative (USTR) FOIA requests
Daily Calendars of US Trade Representative Michael Froman 2013-2016
Daily Calendars of Deputy USTR Robert W. Holleyman II 2014-2016